For the Inventor, By the Inventor

Enter assignee name

Kyoto Pharmaceutical Industries, Ltd.

USPTO Granted Patents = 26

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 107

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Hiroaki Shirahase (13 out of 16 patents)

Masayasu Kasai (10 out of 11 patents)

Hiroshi Matsui (10 out of 14 patents)

4. Akihisa Yoshimi (8 out of 8 patents)

5. Shohei Nakamura (6 out of 11 patents)

6. Yoshimichi Shoji (5 out of 6 patents)

7. Shigemitsu Takeda (5 out of 6 patents)

8. Nobuharu Kakeya (5 out of 6 patents)

9. Shoji Kamiya (4 out of 8 patents)

10. Susumu Nishizawa (4 out of 4 patents)

11. Kazuhiko Kitao (4 out of 7 patents)

12. Yoshinobu Yoshimura (3 out of 4 patents)

13. Hideo Kobayashi (3 out of 3 patents)

14. Satoru Azukizawa (3 out of 3 patents)

15. Katsuo Wada (3 out of 6 patents)

26 patents: Sort by Forward Citations

1. 12378260 - Benzotriazole compound (2025-08-05),

2. 11267797 - Anticancer agent (2022-03-08),

3. 11013728 - Cyclin-dependent kinase 8 and/or 19 inhibitor (2021-05-25),

4. 10377730 - Anticancer agent (2019-08-13),

5. 10059663 - Aromatic compound and use thereof (2018-08-28),

6. 10005752 - Anticancer agent (2018-06-26),

7. 7718377 - Insulin resistance curative and method of screening the same (2010-05-18),

8. 7557123 - Heterocyclic compound and medicinal use thereof (2009-07-07),

9. 7429612 - Indoline compound and medicinal use thereof (2008-09-30),

10. RE38970 - Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors (2006-02-06),

11. 6872732 - Heterocyclic derivatives and medicinal use thereof (2005-03-29),

12. 6589963 - Heterocyclic compounds and salts thereof and medicinal use of the same (2003-07-08),

13. 6410525 - Carbapenem derivatives, utilization thereof and intermediate compounds of the same (2002-06-25),

14. 6342494 - Carbapenem compounds, use thereof, and intermediate compounds of the same (2002-01-29),

15. 6262108 - Medicinal use of cromoglycic acid compounds (2001-07-17),

Kyoto Pharmaceutical Industries, Ltd. is a renowned pharmaceutical company based in Kyoto, Japan. With a strong focus on research and development, we strive to discover innovative drug therapies to improve the quality of life for patients worldwide. Our expertise lies in various therapeutic areas including oncology, neurology, cardiovascular, and infectious diseases. Through strategic partnerships and collaborations, we aim to accelerate the development and commercialization of novel medications. Visit our website to learn more about our cutting-edge research, pipeline of drug candidates, and our commitment to healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#64 in Kyoto 615-0031

#2,456 in Japan

#24,089 in the World

Kyoto Pharmaceutical Industries, Ltd.

Forward Citations = 107

54 inventors:

Hiroaki Shirahase (13 out of 16 patents)

Masayasu Kasai (10 out of 11 patents)

Hiroshi Matsui (10 out of 14 patents)

4. Akihisa Yoshimi (8 out of 8 patents)

5. Shohei Nakamura (6 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…